Pure Global
NCT06384898

Remote Tai Chi for Knee Osteoarthritis

Remote Tai Chi for Knee Osteoarthritis: An Embedded Pragmatic Trial
Tufts Medical Center·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Knee Osteoarthritis
Drug/Device/Intervention
Remote Tai Chi
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Tufts Medical Center
Location
Boston, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2024
End date
Oct 01, 2027
Enrollment
480 participants
Primary outcome

PROMIS Pain Interference score

Summary

The goal of this pragmatic randomized trial is to evaluate the effectiveness of remote Tai
 Chi to treat knee pain in adults with knee osteoarthritis. The main questions the trial aims
 to answer are:
 
 - Does remote Tai Chi improve the extent to which pain interferes with physical, mental,
 and social activities (PROMIS-Pain Interference at 3 months, primary outcome), as well
 as knee pain and function (WOMAC subscales) and analgesic use (secondary outcomes)
 
 - Does remote tai chi decreases healthcare utilization?
 
 Researchers will compare remote Tai Chi added to routine care to routine care alone to see if
 remote tai chi works to treat knee osteoarthritis pain. Participants will participate in
 remotely delivered web-based tai chi sessions, twice a week for 12 weeks, or will continue to
 receive routine care. Participants will be followed for 12 months after randomization.

ICD-10 classifications
Chronic instability of kneeGonarthrosis [arthrosis of knee]Other hypertrophic osteoarthropathyDislocation, sprain and strain of joints and ligaments of kneePatellofemoral disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06384898
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06384898 through Pure Global AI's free database. This phase not specified trial is sponsored by Tufts Medical Center and is currently Not yet recruiting. The study focuses on Knee Osteoarthritis. Target enrollment is 480 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.